Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Healthcare Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Oncolytics Biotech Inc > Panc Biomarker Presentation at ASCO GI 18-20 Jan 2024
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5861)
•••
Comment by Noteableon Dec 31, 2023 6:36pm
175 Views
Post# 35805859

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Panc Biomarker Presentation at ASCO GI 18-20 Jan 2024

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Panc Biomarker Presentation at ASCO GI 18-20 Jan 2024ONCY US Office

4660 La Jolla Village Dr.
Suite 850
San Diego, CA 9212

https://oncolyticsbiotech.com/contact/


La Jolla Center 4660 La Jolla Village Dr

ALL AVAILABLE SPACES(8)

Display Rental Rate as

  • SPACE
  • SIZE
  • TERM
  • RENTAL RATE
  • SPACE USE
  • CONDITION
  • AVAILABLE
  • 3rd Floor, Ste 300
  • 14,332 SF
  • Negotiable
  • $45.00 /SF/YR
  • Office
  • -
  • January 01, 2024
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  • 4th Floor, Ste 450
  • 7,911 SF
  • Negotiable
  • $42.00 /SF/YR
  • Office
  • Full Build-Out
  • Now
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  •  
  •  
  •  
  •  
  • 5th Floor, Ste 540
  • 6,397 SF
  • Negotiable
  • $45.00 /SF/YR
  • Office
  • Full Build-Out
  • Now
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  •  
  •  
  •  
  • 6th Floor, Ste 650
  • 1,759 SF
  • Negotiable
  • $45.00 /SF/YR
  • Office
  • -
  • February 01, 2024
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  • 7th Floor, Ste 750
  • 2,975 SF
  • Negotiable
  • $45.00 /SF/YR
  • Office
  • -
  • June 01, 2024
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  • 8th Floor, Ste 850
  • 3,882 SF
  • Negotiable
  • $45.60 /SF/YR
  • Office
  • -
  • February 01, 2024
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  • 10th Floor, Ste 1020
  • 1,225 SF
  • Negotiable
  • $45.60 /SF/YR
  • Office
  • -
  • March 01, 2024
 
4660 La Jolla Village Dr, San Diego, CA for lease Floor Plan- Image 1 of 1

 

  •  
  • 10th Floor, Ste 1025
  • 2,003 SF
  • Negotiable
  • $45.60 /SF/YR
  • Office
  • -
  • March 01, 2024
https://www.loopnet.com/Listing/4660-La-Jolla-Village-Dr-San-Diego-CA/15123532/

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities